Showing results (31-40 of 153) with videos related to
Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Treatment decisions in palliative cancer care: patients' preferences for involvement and doctors' knowledge about itD Rothenbacher, M P Lutz, F PorzsoltCanadian Journal of Public Health = Revue Canadienne De Sante Publique|January 1, 1989
An evaluation of sources of information on health and travelS J DemeterCureus|January 27, 2017
Helping Health Care Providers and Clinical Scientists Understand Apparently Irrational Policy DecisionsSandor J DemeterOnkologie|February 1, 1987
[Advantages and problems of multicenter therapy studies exemplified by a study of the treatment of metastasizing renal cell carcinoma with recombinant interferon-alpha-2c]D Messerer, F Porzsolt, J Hasford, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-gamma in cancer patientsW Digel, G Zahn, G Heinzel, et al.Leukemia & Lymphoma|January 1, 1994
Paracrine regulation of B-cell growth in hairy cell leukemiaF Porzsolt, M Schmid, G Staib, et al.Medizinische Klinik (Munich, Germany : 1983)|May 15, 1997
[Physicians' attitude in the treatment of incompetent patients. Comparison between East and West Germany]J Richter, M Eisemann, B Bauer, et al.Journal of Immunological Methods|May 2, 1994
Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-alpha and IFN-beta antibodiesO Prümmer, U Streichan, H Heimpel, et al.Oncology|January 1, 1984
Variations in the susceptibility to lysis of NK target cellsF Porzsolt, G Gröger, W Vogel, et al.International Journal of Oncology|May 17, 2011
Immunologically defined subclasses of the growth suppressor protein p53 detected with antibodies in sera from tumor patientsD Hoher, S Kartarius, F Porzsolt, et al.Pageof 16